Publications
189
Citations
37,473
Est. group size
~13
Recurring co-author estimate
Active years
33
Publishing since 1994
Typically publishes in teams of ~9 · 8% small-team papers (≤3 authors) · across 42 venues
- Metabolic Dysfunction–Associated Steatotic Liver Disease and Metabolic Dysfunction–Associated Steatohepatitis–Related Fibrosis: Therapeutic Options and Approaches to Treatment
Annual Review of Medicine · 2026
- Genetic Information Enhances a Novel Non‐Invasive Steatosis Index and Outperforms Existing Steatosis Indices
Liver International · 2026
- LYPLAL1 rare loss-of-function variants in humans and deletion in human hepatoma cells protect against MASLD
Journal of Lipid Research · 2026
- The impact of low-frequency genetic variants on serum protein levels
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Genetic and Genomic Insights Across the SLD Spectrum
Clinical and Molecular Hepatology · 2026
- Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Journal of Clinical Investigation · 2025
- Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease (<scp>MASLD</scp>): A Population‐Based Cohort Study
Alimentary Pharmacology & Therapeutics · 2025
- A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study
JMIR Formative Research · 2025
- LMNA R644C Associates With Hepatic Steatosis in a Large Cohort and Increases Cellular Lipid Droplet Accumulation in Vitro
Gastro Hep Advances · 2025
- WED-496 Anthropometric measures and mortality risk in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD): a population-based cohort study
Journal of Hepatology · 2025
- Precision Medicine, Genetics
Elsevier eBooks · 2025
- Sa1589: ANTHROPOMETRIC MEASURES AND MORTALITY RISK IN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): A POPULATION-BASED COHORT STUDY
Gastroenterology · 2025
- PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease
RWTH Publications (RWTH Aachen) · 2025
- Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank
Nature Genetics · 2024
- Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort
Journal of Hepatology · 2024
- Gastroenterology×17
- Nature Genetics×9
- UNC Libraries×9
- Journal of Hepatology×6
- Liver International×5
- Antonino Oliveri
Medicine · University of Michigan
- Xiaomeng Du
Medicine · University of Michigan
- Annapurna Kuppa
Medicine · University of Michigan
- Chinmay Raut
Medicine · University of Michigan
- Parisa Shabani
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile